Evidence map›Paper›PMID 40119286›Full record

Trial reportBMC anesthesiology2025

Dexamethasone vs. placebo modulation of the perioperative blood immune proteome in patients undergoing total knee arthroplasty.

Asger K Mølgaard, Kasper S Gasbjerg, Ole Mathiesen, Daniel Hägi-Pedersen, Ismail Gögenur

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03506789 (Dexamethasone Twice for Pain Treatment of Total Knee Arthroplasty - A Randomized Blinded Placebo-controlled Clinical Trial), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03506789 phase4completednot on this map

Dexamethasone Twice for Pain Treatment of Total Knee Arthroplasty - A Randomized Blinded Placebo-controlled Clinical Trial

TypeinterventionalSponsorNaestved HospitalRan2018 to 2020Enrolled485ConditionsPostoperative PainArmsDexamethasone, Placebos
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Asger K MølgaardDepartment of Anaesthesiology, Næstved, Slagelse and Ringsted Hospitals, Research Centre of Anaesthesiology and Intensive Care Medicine, Slagelse, Denmark. asman@regionsjaelland.dk.
Kasper S GasbjergDepartment of Anaesthesiology, Næstved, Slagelse and Ringsted Hospitals, Research Centre of Anaesthesiology and Intensive Care Medicine, Slagelse, Denmark.
Ole MathiesenDepartment of Anaesthesiology, Centre of Anaesthesiological Research, Zealand University, Køge, Denmark.
Daniel Hägi-PedersenDepartment of Anaesthesiology, Næstved, Slagelse and Ringsted Hospitals, Research Centre of Anaesthesiology and Intensive Care Medicine, Slagelse, Denmark.
Ismail GögenurDepartment of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPre- and post-operative immune status has gained interest in recent years, as it has been shown to be related to postoperative complications and recovery. The change in immune status has also been known to constitute a large part of the surgical stress response, and it has been speculated that immunomodulatory treatment by glucocorticoids may impact it. Profiling of the impact of specific surgeries and medications on immune status are therefore needed.

methodsWe characterized the postoperative blood immune proteome in 83 patients receiving either placebo (n = 20) or IV 24 mg dexamethasone (n = 60) preoperative before total knee arthroplasty (TKA). The primary outcome was the effect of dexamethasone on total knee arthroplasty surgical stress by comparing postoperative immune proteome in the dexamethasone group and the placebo group. Secondary outcomes were the surgical stress by total knee arthroplasty by comparing pre- to postoperative immune proteome in the placebo group, and the combined effect of surgical stress and dexamethasone by comparing pre- to postoperative immune proteome in the dexamethasone group. Characterization was performed with the Olink Explorer Inflammation panel on blood samples from the biobank for future research collected during the randomized, clinical DEX-2-TKA Trial. Protein change was reported as log2-fold-change and p-values were corrected a.m. Benjamini-Hochberg.

resultsThe surgical stress (placebo) was characterized by a 4.7 log2-fold-change of IL6 (adjusted p-value < 0.01) and up-regulation of central immune signaling pathways and bone marrow mobilization. The combined effect of surgery and dexamethasone showed a less pro-inflammatory profile: IL6 2.5 log2-fold-change (adjusted p-value < 0.01), with decreased signaling for osteoclast activity and innate, immune cell reaction. The effect of dexamethasone showed upregulation of CSF3 (1.55 log2-fold-change, adjusted p-value < 0.01) and an inhibitory effect on both innate and adaptive immune response, immune cell reactivity and formation of extracellular matrix.

conclusionsPreoperative dexamethasone indicated anti-inflammatory properties on both innate and adaptive immune response, while surgery was pro-inflammatory. the combination of total knee arthroplasty and dexamethasone inhibited pathways for osteoclast-activity, indicating possible implications on aseptic prosthesis loosening. Dexamethasone showed strong modulation of the surgical stress response following total knee arthroplasty and future studies must explore the clinical associations of these findings.

trial registrationNCT03506789.

Indexed as

Arthroplasty, Replacement, KneeDexamethasoneGlucocorticoidsProteomeAgedDouble-Blind MethodFemaleHumansMaleMiddle AgedPostoperative ComplicationsDexamethasoneGlucocorticoidsProteomeDexamethasoneKnee arthroplastyOlinkProteomeSurgical stress

Identifiers

PMID40119286
PMCPMC11927264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.